Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome

Amanda B. Abildgaard, Amelie Stein, Sofie V. Nielsen, Katrine Schultz-Knudsen, Elena Papaleo, Amruta Shrikhande, Eva R. Hoffmann, Inge Bernstein, Anne‐Marie Gerdes, Masanobu Takahashi, Chikashi Ishioka, Kresten Lindorff‐Larsen, Rasmus Hartmann‐Petersen

TL;DR

This study reveals that many MLH1 gene variants linked to Lynch syndrome, a hereditary cancer predisposition disorder, lead to protein instability and subsequent degradation. This degradation also affects partner proteins, ultimately causing a loss of DNA repair function. The findings suggest that predicting protein stability could be a valuable tool for diagnosing Lynch syndrome.

What Problem Does This Paper Address?

Lynch syndrome (LS) is a hereditary condition that significantly increases the risk of various cancers, particularly colorectal cancer. It's caused by germline mutations in DNA mismatch repair (MMR) genes, with MLH1 being a key player. A major challenge in diagnosing LS is the presence of many "variants of unknown significance" (VUS) in these genes. It's difficult to determine whether a specific MLH1 variant is pathogenic (disease-causing) or benign, complicating clinical management and genetic counseling. This paper aims to understand the molecular mechanisms behind MLH1 variants and explore how protein stability might explain their pathogenicity, offering a potential diagnostic avenue.

Methods

The researchers employed a multi-pronged approach:

  • In Silico Saturation Mutagenesis and Thermodynamic Stability Predictions: They used computational methods (specifically the FoldX energy function) to predict how every possible single amino acid substitution in the MLH1 protein would affect its structural stability (thermodynamic stability, measured as ΔΔG). This allowed them to create a comprehensive map of potential stability changes across the MLH1 protein.
  • Cellular Assays: They introduced a large set of MLH1 variants into human cell lines (HCT116) and used immunofluorescence microscopy to measure the cellular abundance (steady-state levels) of the MLH1 protein for each variant.
  • Degradation Assays: To investigate why some variants had reduced levels, they used cycloheximide (CHX) to block protein synthesis and observed how quickly MLH1 variants were degraded. They also used bortezomib (BZ), a proteasome inhibitor, to see if degradation was proteasome-dependent.
  • Chaperone Interaction Studies: They examined the interaction of destabilized MLH1 variants with molecular chaperones like HSP70 and HSP90, which are involved in protein folding and degradation.
  • Functional Assays (using existing data): They correlated their findings with previously published data on the functional impact of MLH1 variants (Dominant Mutator Effect - DME).
  • Bioinformatics Analysis: They also incorporated evolutionary sequence energy calculations and analyzed potential effects on RNA splicing.

Datasets

  • gnomAD database: Used to assess the frequency of MLH1 variants in the general population and correlate it with predicted stability.
  • ClinVar database: Used to obtain annotations for MLH1 variants (benign, pathogenic, VUS) for comparison with predicted stability and functional data.
  • Takahashi et al. (2007) functional data: Used to compare predicted stability and cellular abundance with previously established functional classifications of MLH1 variants.

Key Insights and Ideas

  • Stability is Key: The study strongly suggests that structural destabilization is a primary mechanism by which many MLH1 variants cause Lynch syndrome. It's not just about direct disruption of function, but about the protein becoming unstable and being marked for destruction.
  • A Chaperone-Assisted Demise: Destabilized MLH1 variants are recognized and targeted for degradation by the cell's protein quality control machinery, specifically involving the HSP70 chaperone.
  • Domino Effect: The degradation of MLH1 doesn't just affect MLH1 itself; it also leads to the degradation of its essential partner proteins, PMS1 and PMS2, further crippling the DNA mismatch repair system.
  • Predictive Power of Stability: Computational predictions of MLH1 protein stability show a strong correlation with observed cellular levels and functional impact, suggesting this approach can be a powerful tool for classifying VUS.

Key Results

  • Majority are Unstable: A significant portion of disease-linked MLH1 missense variants studied were found at reduced cellular levels.
  • Degradation Pathway: These reduced levels were primarily due to accelerated proteasomal degradation, particularly for variants predicted to be structurally destabilized.
  • PMS1/PMS2 Impact: The loss of MLH1 led to a dramatic destabilization and degradation of its binding partners, PMS1 and PMS2.
  • Correlation with Function: Predicted structural destabilization strongly correlated with reduced steady-state levels and loss-of-function phenotypes (lower DME scores).
  • Diagnostic Potential: Thermodynamic stability predictions, when combined with evolutionary sequence analysis, showed high accuracy (AUC of 0.90) in distinguishing pathogenic from benign MLH1 variants, outperforming some existing tools.

Limitations and Future Work

  • In Vitro vs. In Vivo: While the study uses cell lines, the full complexity of in vivo cellular environments and potential compensatory mechanisms are not fully captured.
  • De-novo vs. Inherited: The study focuses on germline mutations, but the mechanisms might differ for somatic mutations.
  • "Benign" Variants: The study acknowledges that some variants predicted to be stable might still be pathogenic through mechanisms other than structural destabilization (e.g., affecting active sites or binding interfaces).
  • Degron Identification: While HSP70's role is implicated, the precise "degrons" (degradation signals) on MLH1 that are exposed upon unfolding are not fully characterized, and their in silico prediction is currently limited.
  • Therapeutic Avenues: The findings open doors for future research into therapeutic strategies, such as inhibiting the protein degradation pathway for marginally stable MLH1 variants or developing small molecule stabilizers. Further investigation into the interplay between stability, chaperones, and the proteasome is warranted.

Summary updated

Abstract

Defective mismatch repair leads to increased mutation rates, and germline loss-of-function variants in the repair component MLH1 cause the hereditary cancer predisposition disorder known as Lynch syndrome. Early diagnosis is important, but complicated by many variants being of unknown significance. Here we show that a majority of the disease-linked MLH1 variants we studied are present at reduced cellular levels. We show that destabilized MLH1 variants are targeted for chaperone-assisted proteasomal degradation, resulting also in degradation of co-factors PMS1 and PMS2. In silico saturation mutagenesis and computational predictions of thermodynamic stability of MLH1 missense variants revealed a correlation between structural destabilization, reduced steady-state levels and loss-of-function. Thus, we suggest that loss of stability and cellular degradation is an important mechanism underlying many <i>MLH1</i> variants in Lynch syndrome. Combined with analyses of conservation, the thermodynamic stability predictions separate disease-linked from benign <i>MLH1</i> variants, and therefore hold potential for Lynch syndrome diagnostics.
BibTeX
@inproceedings{abildgaard2019computational,
  author = {Amanda B. Abildgaard and Amelie Stein and Sofie V. Nielsen and Katrine Schultz-Knudsen and Elena Papaleo and Amruta Shrikhande and Eva R. Hoffmann and Inge Bernstein and Anne‐Marie Gerdes and Masanobu Takahashi and Chikashi Ishioka and Kresten Lindorff‐Larsen and Rasmus Hartmann‐Petersen},
  title = {{Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome}},
  booktitle = {eLife},
  year = {2019},
  doi = {10.7554/elife.49138},
}
Figure